Multi-system Disorders of Glycosphingolipid and Ganglioside Metabolism

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2010 Mar 10

PMID 20211931

Citations 73

Authors

You-Hai Xu

Sonya Barnes

Ying Sun

Gregory A Grabowski

Affiliations

Soon will be listed here.

Abstract

Glycosphingolipids (GSLs) and gangliosides are a group of bioactive glycolipids that include cerebrosides, globosides, and gangliosides. These lipids play major roles in signal transduction, cell adhesion, modulating growth factor/hormone receptor, antigen recognition, and protein trafficking. Specific genetic defects in lysosomal hydrolases disrupt normal GSL and ganglioside metabolism leading to their excess accumulation in cellular compartments, particularly in the lysosome, i.e., lysosomal storage diseases (LSDs). The storage diseases of GSLs and gangliosides affect all organ systems, but the central nervous system (CNS) is primarily involved in many. Current treatments can attenuate the visceral disease, but the management of CNS involvement remains an unmet medical need. Early interventions that alter the CNS disease have shown promise in delaying neurologic involvement in several CNS LSDs. Consequently, effective treatment for such devastating inherited diseases requires an understanding of the early developmental and pathological mechanisms of GSL and ganglioside flux (synthesis and degradation) that underlie the CNS diseases. These are the focus of this review.

Citing Articles

Impairment of lipid homeostasis causes lysosomal accumulation of endogenous protein aggregates through ESCRT disruption.

Yong J, Villalta J, Vu N, Kukurugya M, Olsson N, Lopez M Elife. 2024; 12.

PMID: 39713930 PMC: 11666243. DOI: 10.7554/eLife.86194.

Sex- and age-associated factors drive the pathophysiology of MASLD.

Yadav A, MacNeill J, Krylov A, Ashrafi N, Mimi R, Saxena R Hepatol Commun. 2024; 8(9).

PMID: 39185904 PMC: 11357696. DOI: 10.1097/HC9.0000000000000523.

Human genetic defects of sphingolipid synthesis.

Dubot P, Sabourdy F, Levade T J Inherit Metab Dis. 2024; 48(1):e12745.

PMID: 38706107 PMC: 11730260. DOI: 10.1002/jimd.12745.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral AL01211 in Healthy Chinese Volunteers.

Dong L, Xiang J, Babcock M, Cheng Y, Wang Y, Shen Y Clin Drug Investig. 2024; 44(6):387-398.

PMID: 38698285 DOI: 10.1007/s40261-024-01362-2.

FAK and p130Cas modulate stiffness-mediated early transcription and cellular metabolism.

Tumenbayar B, Tutino V, Brazzo 3rd J, Yao P, Bae Y bioRxiv. 2024; .

PMID: 38293187 PMC: 10827115. DOI: 10.1101/2024.01.15.575789.

References

Henderson L, Lin L, Prasad A, Paul C, Chang T, Maue R . Embryonic striatal neurons from niemann-pick type C mice exhibit defects in cholesterol metabolism and neurotrophin responsiveness. J Biol Chem. 2000; 275(26):20179-87. DOI: 10.1074/jbc.M001793200. View

Yu R, Nakatani Y, Yanagisawa M . The role of glycosphingolipid metabolism in the developing brain. J Lipid Res. 2008; 50 Suppl:S440-5. PMC: 2674698. DOI: 10.1194/jlr.R800028-JLR200. View

Horowitz M, Wilder S, Horowitz Z, Reiner O, Gelbart T, Beutler E . The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics. 1989; 4(1):87-96. DOI: 10.1016/0888-7543(89)90319-4. View

Ciaffoni F, Tatti M, Boe A, Salvioli R, Fluharty A, Sonnino S . Saposin B binds and transfers phospholipids. J Lipid Res. 2006; 47(5):1045-53. DOI: 10.1194/jlr.M500547-JLR200. View

van Helvoort A, Smith A, Sprong H, FRITZSCHE I, Schinkel A, Borst P . MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 1996; 87(3):507-17. DOI: 10.1016/s0092-8674(00)81370-7. View

Xu C, Sakai N, Taniike M, Inui K, Ozono K . Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet. 2006; 51(6):548-554. DOI: 10.1007/s10038-006-0396-3. View

Kobayashi T, Yamanaka T, Jacobs J, Teixeira F, Suzuki K . The Twitcher mouse: an enzymatically authentic model of human globoid cell leukodystrophy (Krabbe disease). Brain Res. 1980; 202(2):479-83. DOI: 10.1016/0006-8993(80)90159-6. View

Jeyakumar M, Smith D, Williams I, Cortina Borja M, Neville D, Butters T . NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin. Ann Neurol. 2004; 56(5):642-9. DOI: 10.1002/ana.20242. View

Steet R, Chung S, Wustman B, Powe A, Do H, Kornfeld S . The iminosugar isofagomine increases the activity of N370S mutant acid beta-glucosidase in Gaucher fibroblasts by several mechanisms. Proc Natl Acad Sci U S A. 2006; 103(37):13813-8. PMC: 1564243. DOI: 10.1073/pnas.0605928103. View

10.

Kolter T, Sandhoff K . Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu Rev Cell Dev Biol. 2005; 21:81-103. DOI: 10.1146/annurev.cellbio.21.122303.120013. View

11.

Hojjati M, Li Z, Jiang X . Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice. Biochim Biophys Acta. 2005; 1737(1):44-51. DOI: 10.1016/j.bbalip.2005.08.006. View

12.

Verheij M, Bose R, Lin X, Yao B, Jarvis W, Grant S . Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996; 380(6569):75-9. DOI: 10.1038/380075a0. View

13.

Weinreb N, Barranger J, Charrow J, Grabowski G, Mankin H, Mistry P . Guidance on the use of miglustat for treating patients with type 1 Gaucher disease. Am J Hematol. 2005; 80(3):223-9. DOI: 10.1002/ajh.20504. View

14.

Matsuda J, Kido M, Tadano-Aritomi K, Ishizuka I, Tominaga K, Toida K . Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Hum Mol Genet. 2004; 13(21):2709-23. DOI: 10.1093/hmg/ddh281. View

15.

Pastores G, Elstein D, Hrebicek M, Zimran A . Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies. Clin Ther. 2007; 29(8):1645-54. DOI: 10.1016/j.clinthera.2007.08.006. View

16.

Elliot-Smith E, Speak A, Lloyd-Evans E, Smith D, van der Spoel A, Jeyakumar M . Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis. Mol Genet Metab. 2008; 94(2):204-11. DOI: 10.1016/j.ymgme.2008.02.005. View

17.

Strazza M, Luddi A, Carbone M, Rafi M, Costantino-Ceccarini E, Wenger D . Significant correction of pathology in brains of twitcher mice following injection of genetically modified mouse neural progenitor cells. Mol Genet Metab. 2009; 97(1):27-34. DOI: 10.1016/j.ymgme.2009.01.005. View

18.

Bramham C, Messaoudi E . BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol. 2005; 76(2):99-125. DOI: 10.1016/j.pneurobio.2005.06.003. View

19.

Montano A, Oikawa H, Tomatsu S, Nishioka T, Vogler C, Gutierrez M . Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice. Mol Genet Metab. 2008; 94(2):178-89. DOI: 10.1016/j.ymgme.2008.01.007. View

20.

dAzzo A, Tessitore A, Sano R . Gangliosides as apoptotic signals in ER stress response. Cell Death Differ. 2006; 13(3):404-14. DOI: 10.1038/sj.cdd.4401834. View